menu
    • menu

    Company profile for KemPharm

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    From our founding in 2006, KemPharm® has been and continues to be a prodrug discovery company focused on building a portfolio of prodrugs that represent an improvement over currently approved drugs and address unmet medical needs in large, established markets. Our LAT™ prodrug discovery technology seeks to improve the properties of existing drugs by identifying pharmaceuticals that address a large patient population wher...
    From our founding in 2006, KemPharm® has been and continues to be a prodrug discovery company focused on building a portfolio of prodrugs that represent an improvement over currently approved drugs and address unmet medical needs in large, established markets. Our LAT™ prodrug discovery technology seeks to improve the properties of existing drugs by identifying pharmaceuticals that address a large patient population where conversion to a prodrug could enable better treatment outcomes, alleviate unwanted or unintended side-effects or enhance the marketability of the drug.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    KemPharmUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1180 Celebration Boulevard Suite 103 Celebration, FL 34747
    Telephone
    Telephone
    888.958.1253
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://kempharm.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/kempharm-inc./
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/kempharm

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Corrected: Zevra CEO hits the exit as minority shareholder's nominees
    Corrected: Zevra CEO hits the exit as minority shareholder's nominees

    08 May 2023

    // Tyler Patchen ENDPTS

    https://endpts.com/zevra-ceo-resigns-as-board-of-directors-sees-change/

    Tyler Patchen ENDPTS
    08 May 2023
    Share Share
    Recursion acquires two AI-based drug discovery companies in $87.5M deal
    Recursion acquires two AI-based drug discovery companies in $87.5M deal

    08 May 2023

    // Katherine Lewin ENDPTS

    https://endpts.com/recursion-acquires-valence-and-cyclica-two-ai-drug-discovery-companies-for-87-5m/

    Katherine Lewin ENDPTS
    08 May 2023
    Share Share
    KemPharm Announces Corporate Name Change to Zevra Therapeutics
    KemPharm Announces Corporate Name Change to Zevra Therapeutics

    22 Feb 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/02/22/2613277/16626/en/CORRECTION-KemPharm-Announces-Corporate-Name-Change-to-Zevra-Therapeutics.html

    GLOBENEWSWIRE
    22 Feb 2023
    Share Share
    KemPharm Enhances Senior Management Team
    KemPharm Enhances Senior Management Team

    31 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/01/31/2598307/16626/en/KemPharm-Enhances-Senior-Management-Team.html

    GLOBENEWSWIRE
    31 Jan 2023
    Share Share
    KemPharm Issues Letter to Shareholders
    KemPharm Issues Letter to Shareholders

    24 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/01/24/2594089/16626/en/KemPharm-Issues-Letter-to-Shareholders.html

    GLOBENEWSWIRE
    24 Jan 2023
    Share Share
    KemPharm Partners with Hypersomnia Foundation for Sleep Disorder Research
    KemPharm Partners with Hypersomnia Foundation for Sleep Disorder Research

    18 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/01/18/2590811/16626/en/KemPharm-Partners-with-the-Hypersomnia-Foundation-to-Support-Sleep-Disorder-Research-and-Advocacy.html

    GLOBENEWSWIRE
    18 Jan 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search